Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases. 1982

H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki

Cerebrospinal fluid gamma-aminobutyric acid (CSF-GABA) was analysed by radioreceptor assay in 16 normal controls and 84 patients with various neurological and psychiatric diseases. In patients with spinocerebellar degeneration, neuro-Behçet's syndrome and Parkinson's disease, CSF-GABA levels were decreased. On the other hand, increased CSF-GABA levels were detected in patients with meningitis.

UI MeSH Term Description Entries
D008297 Male Males
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
May 1986, Rinsho shinkeigaku = Clinical neurology,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
January 1966, Rivista di neurologia,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
June 1959, Klinische Wochenschrift,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
June 1999, Acta neurologica Scandinavica,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
August 1982, Acta neurologica Scandinavica,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
January 1983, Archiv fur Psychiatrie und Nervenkrankheiten,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
April 1983, Annals of neurology,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
April 1984, Arerugi = [Allergy],
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
February 1970, The Journal of clinical endocrinology and metabolism,
H Kuroda, and N Ogawa, and Y Yamawaki, and I Nukina, and T Ofuji, and M Yamamoto, and S Otsuki
August 1988, Rinsho shinkeigaku = Clinical neurology,
Copied contents to your clipboard!